Attached files
file | filename |
---|---|
8-K - FORM 8-K - VION PHARMACEUTICALS INC | y02853e8vk.htm |
Exhibit 99.1
IN THE UNITED STATES BANKRUPTCY COURT
FOR THE DISTRICT OF DELAWARE
FOR THE DISTRICT OF DELAWARE
In re: Vion Pharmaceuticals, Inc.
|
: | Chapter 11 | ||
: | Case No. 09-14429(CSS) | |||
Debtor.
|
: |
INITIAL MONTHLY OPERATING REPORT
File report and attachments with Court and submit copy to United States Trustee within 15
days after order for relief.
Certificates of insurance must name United States Trustee as a party to be notified in the event of
policy cancellation Bank accounts and checks must bear the name of the debtor, the case number, and
the designation Debtor in Possession. Examples of acceptable evidence of Debtor in Possession
Bank accounts include voided checks, copy of bank deposit agreement/certificate of authority,
signature card, and/or corporate checking resolution.
Document | Explanation | |||||||
REQUIRED DOCUMENTS | Attached | Attached | ||||||
12-Month Cash Flow Projection (Form IR-1) |
YES | NO | ||||||
Certificates of Insurance: |
||||||||
Workers Compensation |
YES | NO | ||||||
Property |
YES | NO | ||||||
General Liability |
YES | NO | ||||||
Automobile Liability |
YES | NO | ||||||
Umbrella Liability |
YES | NO | ||||||
Product Liability |
YES | NO | ||||||
Product Liability SERP |
YES | NO | ||||||
D&O |
YES | NO | ||||||
D&O Side A |
YES | NO | ||||||
Employment Practices Liability |
YES | NO | ||||||
Fiduciary Liability |
YES | NO | ||||||
Clinical Trial Liability CLI037 France |
YES | NO | ||||||
Clinical Trial Liability CLI043 France |
YES | NO | ||||||
Clinical Trial Liability CLI043 Germany |
YES | NO | ||||||
Other: |
||||||||
Evidence of Debtor in Possession Bank Accounts |
||||||||
Tax Escrow Account |
YES | NO | ||||||
General Operating Account |
YES | NO | ||||||
Other: |
YES | NO | ||||||
Retainers Paid (Form IR-2) |
YES | NO |
I declare under penalty of perjury (28 U.S.C. Section 1746) that this report and the documents
attached are true and correct to the best of my knowledge and belief.
/s/ Karen Schmedlin
|
December 28, 2009
|
|||
Karen Schmedlin
|
VP Finance, Chief Accounting Officer and Secretary
|
* | Authorized Individual must be an officer, director or shareholder if debtor is a corporation; a partner if debtor is a partnership; a manager or member if debtor is a limited liability company |
12-Month Cash Flow Projection (Form IR-1)1
1 | The data is not presently available to support an accurate 12-month cash flow projection. The Debtor is therefore providing a 13-week budget. |
Vion Pharmaceuticals, Inc. |
Case No.: 09-14429(CSS) | |
Cash Flow Projections for the 13 Week Period: 12/17/2009 through 3/19/2010 |
Actual | Actual | Actual | Forecast | Forecast | Forecast | Forecast | Forecast | Forecast | Forecast | Forecast | Forecast | Forecast | Forecast | Forecast | ||||||||||||||||||||||||||||||||||||||||||||||||
Stub 12/17-18 | W/E 12/25 | W/E 1/1 | W/E 1/8 | W/E 1/15 | W/E 1/22 | W/E 1/29 | W/E 2/5 | W/E 2/12 | W/E 2/19 | W/E 2/26 | W/E 3/5 | W/E 3/12 | W/E 3/19 | 13 Week Total | ||||||||||||||||||||||||||||||||||||||||||||||||
Cash, Beginning Balance |
14,365,000 | 14,365,000 | 14,365,000 | 14,239,942 | 14,093,365 | 13,948,629 | 13,977,800 | 13,345,623 | 13,297,657 | 13,056,415 | 13,028,380 | 12,223,863 | 12,092,252 | 11,993,399 | 14,365,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Receipts: |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Technology License Revenues |
1,000 | 1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment Interest Income |
200 | 200 | 150 | 550 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Insurance Refunds |
57,706 | 57,706 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sales of Assets |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Receipts |
| | | 200 | | 57,706 | 1,000 | 200 | | | | 150 | | | 59,256 | |||||||||||||||||||||||||||||||||||||||||||||||
Disbursements: |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payroll, Taxes and Benefits |
0 | 0 | 124,758 | 52,177 | 134,276 | 325 | 158,588 | 325 | 130,781 | 325 | 238,203 | 325 | 92,603 | 325 | 933,012 | |||||||||||||||||||||||||||||||||||||||||||||||
Outside Tests, Services and Lab Supplies |
0 | 0 | 0 | 430 | 1,210 | 210 | 5,210 | 430 | 210 | 210 | 5,210 | 0 | 0 | 0 | 13,120 | |||||||||||||||||||||||||||||||||||||||||||||||
Clinical Trials |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,500 | 0 | 0 | 0 | 9,000 | 0 | 0 | 13,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Drug Storage and Handling |
0 | 0 | 0 | 0 | 0 | 0 | 5,250 | 0 | 0 | 0 | 5,250 | 0 | 0 | 0 | 10,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Professional Fees Debtor(2) |
0 | 0 | 0 | 6,850 | 500 | 20,000 | 303,004 | 4,000 | 4,500 | 20,000 | 333,204 | 6,525 | 500 | 40,000 | 739,083 | |||||||||||||||||||||||||||||||||||||||||||||||
Professional Fees Creditors Committee(2) |
0 | 0 | 0 | 0 | 0 | 0 | 120,000 | 0 | 0 | 0 | 120,000 | 0 | 0 | 0 | 240,000 | |||||||||||||||||||||||||||||||||||||||||||||||
US Trustee Fees |
0 | 0 | 0 | 0 | 0 | 0 | 975 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 975 | |||||||||||||||||||||||||||||||||||||||||||||||
Facilities and Related |
0 | 0 | 300 | 41,911 | 750 | 0 | 31,650 | 33,911 | 750 | 0 | 31,650 | 33,911 | 750 | 0 | 175,583 | |||||||||||||||||||||||||||||||||||||||||||||||
Sales, Use and Other Taxes and Licenses |
0 | 0 | 0 | 37,409 | 500 | 0 | 0 | 0 | 0 | 0 | 10,000 | 0 | 0 | 0 | 47,909 | |||||||||||||||||||||||||||||||||||||||||||||||
Business Insurance |
0 | 0 | 0 | 0 | 0 | 0 | 2,500 | 0 | 0 | 0 | 2,000 | 27,000 | 0 | 0 | 31,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Business Travel |
0 | 0 | 0 | 3,000 | 2,500 | 3,000 | 1,000 | 0 | 0 | 2,500 | 4,000 | 0 | 0 | 2,500 | 18,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Other |
0 | 0 | 0 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 55,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Shutdown/Disposal Costs-Lab, Drug, Facility |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100,000 | 0 | 50,000 | 50,000 | 0 | 50,000 | 250,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Total Disbursements |
| | 125,058 | 146,777 | 144,736 | 28,535 | 633,177 | 48,166 | 241,241 | 28,035 | 804,517 | 131,761 | 98,853 | 97,825 | 2,528,682 | |||||||||||||||||||||||||||||||||||||||||||||||
Net Cash Flow |
| | (125,058 | ) | (146,577 | ) | (144,736 | ) | 29,171 | (632,177 | ) | (47,966 | ) | (241,241 | ) | (28,035 | ) | (804,517 | ) | (131,611 | ) | (98,853 | ) | (97,825 | ) | (2,469,426 | ) | |||||||||||||||||||||||||||||||||||
Cash, Ending Balance(1) |
14,365,000 | 14,365,000 | 14,239,942 | 14,093,365 | 13,948,629 | 13,977,800 | 13,345,623 | 13,297,657 | 13,056,415 | 13,028,380 | 12,223,863 | 12,092,252 | 11,993,399 | 11,895,574 | 11,895,574 | |||||||||||||||||||||||||||||||||||||||||||||||
(1) Ending Cash Balance excludes certain discretionary vendor payments which, in the
event that certain assets(s) are sold, would be necessary to complete study/test reports and return
all study/test/process documentation to Vion/buyer.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Actual | Actual | Actual | Forecast | Forecast | Forecast | Forecast | Forecast | Forecast | Forecast | Forecast | Forecast | Forecast | Forecast | |||||||||||||||||||||||||||||||||||||||||||||||||
Stub 12/17-18 | W/E 12/25 | W/E 1/1 | W/E 1/8 | W/E 1/15 | W/E 1/22 | W/E 1/29 | W/E 2/5 | W/E 2/12 | W/E 2/19 | W/E 2/26 | W/E 3/5 | W/E 3/12 | W/E 3/19 | |||||||||||||||||||||||||||||||||||||||||||||||||
Ending Cash, assuming asset(s) not sold |
14,365,000 | 14,365,000 | 14,239,942 | 14,093,365 | 13,948,629 | 13,977,800 | 13,345,623 | 13,297,657 | 13,056,415 | 13,028,380 | 12,223,863 | 12,092,252 | 11,993,399 | 11,895,574 | ||||||||||||||||||||||||||||||||||||||||||||||||
Discretionary vendor cumulative payments |
| | | | | | | | | | | 398,804 | 407,804 | 407,804 | ||||||||||||||||||||||||||||||||||||||||||||||||
Ending Cash, assuming asset(s) sold |
14,365,000 | 14,365,000 | 14,239,942 | 14,093,365 | 13,948,629 | 13,977,800 | 13,345,623 | 13,297,657 | 13,056,415 | 13,028,380 | 12,223,863 | 11,693,448 | 11,585,595 | 11,487,770 | ||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(2) Payments to Retained Professionals during the post-petition period reflect a 20% holdback which is assumed paid the week ending 5/1/10. |
Certificates of Insurance
PRODUCER ACORD CERTIFICATE IS ISSUED AS A MATTER OF INFORMATION ONLY AND Aon Risk services Northeast Inc. comfers no rights upon the certificate holder.this certificatb Stamford cr office DOES NOT AMEND, EXTEND OR ALTER THE COVERAGE AFFORDED BY THE 1600 Summer Street POLICIES below. Stamford cr 06907-4907 usa COMPANIES AFFORDING COVERAGE Phone.(866) 283-7122 Fax- (847). 953-5390 company A Federal Insunce company INSURED COMPANY fc vion Pharmaceuticals » j| Four science park rnunANv b New Haven CT 06511 USA company J ^ £ COMPANY ~~~~~~ ~ j| [ P h___^___1 INDICATED, NOTWITHSTANDING ANY REQUIREMENT, TERM OR CONDITION Or ANY CONTRACT OR OTHER DOCUMENT WITH RESPECT TO WHICH THIS CERTIFICATE MAY BE ISSUED OR MAY PERTAIN, THE iNSURANCE AFFORDED BY TO POLICIES DESCRIBED HEREIN IS SUBJECT TO AIL THE TERMS. EXCLUSIONS AND CONDiTiONS OF SUCH POLICIES. LIMITS SHOWN MAY HAVE BEEN REDUCED BY PAID CLAIMS. CO Tyre OF INSURANCE POUCV NUMBER POLICY EFFECTIVE OUCY EXPIRATTO COVERED PROPERTY LIMITS WH DATE(MWDDnfY) DATE (MIWNWYY) ___. x | pnor,;^~~ 35797180 12/15/69 : 12/15/10 _| building~~ CAUSES Of LOSS PERSONAL !RQPDRTY ~1 basic BUSINESS INCOME BAilc ___irfoB»»» r»pt«M ___~___BROAD EXTRA EXPENSE ~ SPECIAL BlANKCTBWLDWa g reAWHQUAKB T_nt»mm*m» ,00.000 | flood ___»wMKBrBioo*pp R ~ x Deductible ss.ooo 3 ~ ^ X^ BI & EE tZ,025,000 INWNO MARINE TYHIi OF POLICY ~"X .. v J3 CAUSBSOFtOSS ~~ g |NAMEt>PClULS ~ ___jg g oTnert _^_«___g ___-.. i... ___«^,___.._-~___. ___,,___ss= . ___^ S CRIME fi TYPE OH POLICY 0 I BOILER S MACIfIWRY ___J OTHER ~ ( ~ LOCATION OF PREMISES V DESCRIPTION OF PROPERTY E53 »§{ Locations: 1- 2S5 Long Beach Blvd., Stratford, CT 06615. 2. 1 science park, New Haven, cr 06511. 3, 5 science S| park, New Haven, CT 06511, 4, 645 science Drive, Madison, wi 53711. 5. 2661 Audubon Rd, Audibon, pa 19403, 6, e»-i 9 charlestown Road, Eagoe industrial Estate, ire. 7. 1100 Kennedy Road, Windsor, ct 06095- 53! SPECIAL CONDITIONS /OTHER COVERAGES ~~~~~~ ==""'~ . ~""= ~* ** ^g Upon receiving any notice of cancellation regarding the listed policies, notify Certificate Holder, ^^ SHOULD ANY OF THE ABOVE DESCRIBED POLICIES BE CANCELLED BEFORE THE 3SE United States Dept of Justice bxpiration pate rHEiteop tub issuing company will endeavorto mail ^^ officer of the United States trustee joOAYSwwnEN notice to the CEtmncATE holder namspto the leh-. ^^ C/O JOSepllJ. MCMahOn, Jr., ESIJUire DUTFAItWETOMAlLSUCHNOTICESIIALUMIWENOOaUOATIONORLIAOIUTY ^* 3. Caleb Boggs Federal Building of any kind upon the company, its aoentsor representatives, 2S5 ^^yrfau"07-""^35 |^s===^^ &m*si^jK«L*jL& |
Attachment to ACORD Certificate for vi on Pharnraceutl cal s The terms, conditions and provisions noted below are hereby attached to the captioned certificate as additional description of the coverage afforded by the insurers). This attachment doss not contain all terms, conditions, coverages or exclusions contained in the policy INSURED I ---- - ___Vion Pharmaceuticals COMPAMES APFDBD1NOCOVERAGE Four science park company New Haven CT 06511 USA COMPANY COMPANY ~ _»»«^___COMPANY ~"~ ~ j If a policy below docs not include limit information, refer to the corresponding policy on the ACORD ADDITIONAL POLICIES certificate form for policy limits- £° TypeortHimntt Policy Number po^IE gj Limiu ~~~ PROPERTY ~ -~- ~ ~~ ~ - -p - ~ a 357971BO 12/1S/09 12/15/10 Earthquake Dec $1,000,000 Earthquake ftgg 51,000,000 earthquake oed S25.000 Flood occ (1,000,000 Flood Agg $1,000,000 Flood Ded $50,000 LOCATION OP PI!EMJSES\ DESCRIPTION OF PROPERTY |
^£§&* CERTIFICATE OF LIABILITY INSURANCE | ^$S9)~~~\ PRODUCER . -ervice jorth-aZt lnc "~ ~~~ ITHJS CERTIFICATE IS ISSUED AS A MATTER OF INFORMATION ONLY Stamford CT Office AND CONFERS NO RIGHTS UPON THE CERTIFICATE HOLDER. THIS 1600 Summer Street CERTIFICATE DOES NOT AMEND, EXTEND OR ALTER THE Stamford CT 06907-4907 USA COVERAGE AFFORDED BY THE POLICIES BELOW, ..oKE.case) aa-na «-(84n 953-5390 sAFFORBING COVERAGE I NA1C uajunEo IN5WERA; Federal insurance Company 20281 ^ vion Pharmaceuticals insurers: £ Four Science Park . * New Haven CT 065U USA insurer a 8 .. - 2 jjjjjUMKOi £ ^^^^^^^^^^^^^^^^^^_^.^^^^^^_^^^^___^_^___INSURER!: ...,._,,,,, * COVERAGES W THE POLICIES OF INSURANCE LISTED BELOW HAVE BEEN ISSUED TO THE INSURED NAMED ABOVE FOR THE POLICY PERIOD INDICATED NOTWITHSTANDING I ANY REQUIREMENT, TERM OR CONDITION OP ANY CONTRACT OR OTHER DOCUMENT WITH RESPECT TO WHICH THIS CERTIFICATE MAY BE ISSUED OR MAY ACOREaktE LIMITS SHOWN MAY HAVE BEEN REDUCED BY PAID CLAIMS UMITS SHOWN ARE AS REQUESTED Tin insrd type of insurance roucY number folicy effective policy expiration limits ,^_^-___PATEIMM/DP/YYYY! PATE(MM/nP>YYVY) .,,,,,.,,,-.- _ ,,,-.,..,.-,,, A SMERAHJAB1UTY 357971BO 12/15/2009 12/15/2010 EACH OCCURRENCE r ~ nToOO.oOO P* COMMERCIAL OENBItAlUABIUrV DAMAOBTO RENTED 11,000,000 | I fn PgMBEStl&OKmTCiim) ___CI-A1M5MAOE |X | OCCUR ^KDfeXFJAnyoiicpcnop) Jxo,000 L. _^___PBISONAL&ADV INJURY $1,000,000 § - ___ CO I I ,_m.______GENERAL AGGREGATE 12,000,000 ^ awtMataMTEUMTAmnniL products .comp/opaog i^W 3 srauCT a %& a ^ g _ MifdMOJitJiiMXmlJTY 735-5-77-01 12/15/2009 12/15/2010 COMBINED51X01^1!^ ~ "*"~ o I ] ANYAUTO (ftucclfcni) 51,000,000 ~Z. r AU-OWNED AUTOS BODILY INJURY ~ I r~ SCHEDULEDAUTCB (Perperson) g |T H!WD AUTOS BODILY !WURY ~~~~ ~~ ~ 3 pT NON OWNED AUTOS .fF"'"ld°") ___| PROPERTY DAMAOG u_* ** - ^.«-. (p« KClttom) CARACE 14ABII.ITV AUTO ONLY. Eft ACCIDENT B ANTftUTO OTHER THAN BAACC ; MTOOHLY. ~^- A EXCm/UMDRElWtlAI)!l,rrY 79816672 12/15/2009 12/15/2010 BACH OCCURRENCE fSTOOO.OOO 3 occtw r~| CLAIMS MADIs AGOREOATB 55,000,000 ^DEDUCTIBLE ~ (RETENTION ,,»___-___-___. ,,,, ___I .,,,,..,___..,,._,,,..,.. , . A WomCSWCOM^AT.ONANB 7^3^ ^ H/15/2009 WiW/UlU X JWC| STATU. | jOTHr WUWWMMlUfV pj ^SSilT M 5506^00 = ANYPROi-IUBTOR/PARTNiiR/EXECUnVE LJ " ffig OWCEIUMBMBEREXCLUDED? EL D1SEASE-EA 6MPI.OY1;E 1500,000 gS rrdr»rj«SpEclALrRoTOIoNs^ ..^.^^^1^1 iM0.oo0g . ^_ ._.-.- ~ . i~^f OTHER M DESCRIPTION OPOPERATIONWLOCATIONSAEHICLES/EXCI.USIONS ADDED PY ENDORSEMENT/SPECIAL PROVISIONS ~ §jf Upon receiving any notice of cancellation regarding the li$ted policies, notify certificate Holder- - See Attached #w Addendum iffl CERTIFICATOHCMIDER ~~ "^___C^CKLLATn^^ ''^^~"~~~ ___../Il^ll ^ ___ ~"^ United States Dept Of JUStiCe SHOUtDANYOFTHBABOVBDESCRlBEDPOLiaESBECANCELLBOBEFORBTHEEXWaATION gj officer of the united States Trustee date thereof, the issuing insurer will endeavorto mail gS r/O to^PDh 1 MCMahon 3F ESOUire U DAYSWRITTENHOTtCaTOTMECeilTIFICATEHOLDEIlNAMEDTOTHEL.BT. 3TJ c/o josepn j, Mcwanon, jr., tsquire out failure to oo so skau, impose no oblioation or uability S5 3. Caleb Boggs Federal Building or any icmo upon toe wsunBR.rrSAOEOTS on representatives l-ffi 841 King Street, suite 2207, Lockbox 35 , . KJ Wilmington de 1980X USA | authoiu^drepresentative j^ m*?>5£^,sf£>&*t^ g ACORO 2S (ZOOJ/01) ©19S8-2009 ACORD CORPORATION. All rlglns roservcdS The ACORD name and logo arc registered marks of ACORD * |
I ADDENDUM TO CERTIFICATE OF INSURANCE Insurers Name: Vion Pharmaceuticals Four Science Park New Haven, CT 06511 -USA Certificate Holders; United States Dept of Justice Office of the United States Trustee c/o Joseph .1. McMahon, Jr., Esquire J. Caleb Boggs Federal Building 844 King Street, Suite 2207, Lockbox 35 Wilmington, DEI 9801 Insurer Type Policy Eff/Exp Limits Federal Ins Co. Prod Liab ,35797200 12/15/09-10 10,000,000 Prod/Comp Agg 10,000,000 Prod/Comp Occ Federal Ins Co SERP ** 35797200 12/15/09-Un)imited IL National Ins Co- D&O * 012436449 JO/15/09-15 10,000,000 Limit 500,000 Retention XL fns Specialty D&O Side A * ELU11506709 12/14/09-10/15/15 5,000,000 Aggregate IL National Ins Co, Empl Pratice Liab* 012483784 10/15/09-15 5,000,000 Aggregate 25,000 Retention IL Nationallns Co. Fiduciary Liab * 01Z484029 10/15/09-15 5,000,000Aggregate 10,000 Retention Vigilant Ins Co. Woridnet Policy 35783462 10/15/09-10 General Liab 1,000,000 Adv Inj 1,000,000 Occ 1,000,000 Prem 1,000,000 Agg 10,000 Medical Auto Liab 1,000,000 Hired Non-Owned Foreign WC 500,000 Bl Accident 500,000 Bl D Limit 500,000 Bl D Bach * Run Off Coverage Purchased ** Supplemental Extended Reporting Period |
PRODUCER THIS raRTiiplCAfi IS ISSUED AS A MATTER OP INFORMATION ONLY AND CONFERS NO RIGHTS r s,r 0(CmM snpi-e s~js«^-5 1600 Summer Street AITER THg COVERftCE Ai=FORDED BV THE POUCIES BELOW. Stamford, CT 06907USA INSURERS APPOR0IHC COVERAGE (203)326-7555 Fax; (203)326-7510 INSURER A Gerling insured ~ ~~ ~ ~ insurer b~ ~~~~ ~~~ Vlon Pharmaceuticals ,,___ . Four Science Park ******** INSURER D New Haven, CT 06511 USA . . ,_.___INSURER IB THIS IS TO CERTIFY THAT THE POUCIES OF INSURANCE LISTED BELOW HAVE BEEN ISSUED TO THE INSURED NAMED ASOVE FOR THE POLICY PERIOD INDICTED, NOTWITHSTANDING ANY REQUIREMENT, TERM OR CONDITION OF ANY CONTRACT OK OTHER DOCUMENT WITH RESPECT TO WHICH THIS CERTIFICATE MAY BE ISSUED OR MAY PERTAIN THE INSURANCE AFFORDED BY THE POLICIES DESCRIBED HEREIN IS SUBJECT TO ALL THE TERMS, EXCLUSIONS AND CONDITIONS OF SUCH POUCIES. LIMITS SHOWN MAY HAVE BEEN REDUCED BY PAID CLAIMS « j TVPBOFlNGUHnHCB ~~ ~| POUCY HUMBBRI POUCVEFFECT!WB I POUCY DXPIREAT10N I ~~ UMIT lit \ |; OfttE IHWPO/VY) nt»B IMH/PO<YYI A GENEHHl LIAnltirV , COMMERCIfll CDHCRfll UABIltTY OBtEKALASOHESATE ___~n rn ..! I dAIMSMADE | | OCCUR fROPUCtS-COMIVOI AGO OWNERS i CONTRACTORS PROT PEREOHAUtAlW INJURY EACH.pccuimBKai ~** TOOPBITYIJAMMJE M8J,|!Jjjij)iENDe ~ ^ | m n ___{rtlfypnopciain> ___AUTOMOBIHIUAJMUTV AKYAUTO COMBIHECI6INSI.E1.IMIT ~~ BDOK.Y INJURY ni.i.owciic autos iPERfensom BODILY INJURY ~~ * ~~~ KWIXHED AUTOS 1FERACCIPEHT] ___ misowmf property pawse NON-OWNED AUTOS ___^_^_»___CARACH immuTY AUTOONUYEAACCIPEMT AWYAUTO OTHER THAU AUTO ONLY J..Ji;ii!-..j: . . V EACH ACCIDENT r : ___.,,.___, , , AOCBEgATg CXceSS MBOIlltY EACHOCCURBgHCB B UMOI,EU-A FORM AOOHEOATe OTHER THAN UM8REIU FORM WOBKBHS CO MI»B«SATIOH UNO I u_., , .~TH :;.\-( :;::: -.: UfcOlOVKHS UA0IUW ) V^smumyLtnt g. ,,|: ..^,,:.,...... ;... eieACHAcctpENr IKS PHOPWETOW PMTNWG/BXECUTIVB B. BCEASE.POUCY UMIT OFFICERS Att£ j I INOL ~~~ ~ E».DI»«liEA6H«PlQYKE ______EXCt ~~ . ___A Clinical Trial Liability CLI037 France 168090124 09/01/64 09/30/10 ~ Clinical Trial Liability CLI043 France 16.B0910Z5 06/01/06 06/01/10 Clinical Trial Liability CU 043 Germany 70-005904253-2 08/01/06 06/30/10 DESCRIPTION OF QPERATIONSaOCATIONB/VEHICies/EXCLUSlONS ADDBO BV ENDORSEMENT/SPECIAL PROVISIONS ~ ~~~~ ~ Upon receiving gny notice of cance|lailon regarding the Usteti^ pplicles, notify Gertincate Holder. {___r United states Dep! of Justice ~ i sHOLiLD any of the above described policies be canceled office of the United States Trustee before the expiration date thereof, the issuing company will r/o JniHOh J McMahon Jr Esaulre ENDEAVOR TO MAIL 30 DAYS WRITTEN NOTICE TO THE CERTIFICATE MrZh Bnnn, ^riB«?B»!lrfh,T HOLDER NAMED T0 THE LEFT- BUT FAiLUR6 TO MftlL SUCH NOTICE o^f o, . o ? l^ i 11, «b SHALL IMPOSE NO OBLIGATION OR LIABILITY OF ANY KIND UPON THE 844 King Street, Suite 2207, Lochbox 36 company. its agents or representatives Wilmington, DE 19801 USA AUTHORIZED REPRESENTATIVE Afartin Weidmmat, Aon Risk Services of Connecticut, Inc. |
Evidence of Debtor in Possession Bank Accounts |
ORIGINAL IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE « ww.» «,,___ww»~w-»*-- -""*» ** ta-n^X In re: Chapter 11 V1ON PHARMACEUTICALS, INC., Case No. 09-14429 (CSS) Debtor.1 Rc: Docket No, 5 ORDER (I) APPROVING CONTINUED USE OF CASH MANAGEMENT SYSTEM, <H) AUTHORIZING USE OF PREPETITION BANK ACCOUNTS AND EXISTING CHECKS AND (HI) GRANTING INTERIM RELIEF FROM THE REQUIREMENTS CONTAINED IN BANKRUPTCY CODE S 3450>) Upon consideration of the motion (the Motion)2 of the debtor and debtor-in-possession (the Debtor) in the above-captioned case for the entry of an order (i) authorizing and approving the Debtors continued use of its existing Cash Management System and protections for the relevant cash management banks, (ii) authorizing and approving the Debtor to continue using pre-petition bank accounts and existing checks, and (iii) granting interim relief from the requirements contained in Bankruptcy Code § 345(b); and upon consideration of the Motion and all pleadings related thereto; and the Court finding that (a) it has jurisdiction over the matters raised in the Motion pursuant to 28 U.S.C, §§ 157 and 1334, (b) this is a core proceeding pursuant to 28 U.S-C. § I57(b)(2), and (c) proper and adequate notice of the Motion and the hearing thereon has been given under the circumstances and that no other or further notice is 1 The Debtor in this case, along with the fast four digits of the federal tax identification number for Ihe Debtor, is Vion Pharmaceuticals, Inc. (1221), The Debtors corporate offices are located at 4 Science Park, New Haven, Connecticut 06511. 2 Capitalized terms not defined herein shall have the meanings ascribed to them in the Motion |
necessary; and the Court finding that the relief requested in the Motion is in the best interests of the Debtor, its estate and creditors; and after due deliberation and good and sufficient cause appearing therefore, it is hereby: ORDERED, that the Motion is granted as provided herein; and it is further ORDERED, that this Order shall be final in all respects except as to relief granted relating to 11 U.S.C. § 345(b), which shall be interim in nature, effective for a period from the Petition Date through and including the date that is seventy-five (75) days after the Petition Date (the Interim Period); and it is further ORDERED, that subject to the provisions of this Order, the Debtor is authorized, in the reasonable exercise of its business judgment, to (i) designate, maintain, and continue to use, with the same account numbers, all of its bank accounts in existence on the Petition Date, including, without limitation, the bank accounts identified in Exhibit TA of the Motion, (ii) use its present forms and other documents related to the Bank Accounts, (iii) treat such Bank Accounts for all purposes as accounts of the Debtor as debtor-m-possession account, and (iv) preserve the reporting and accounting mechanisms used by the Debtor in respect of the Bank Accounts; and it is further ORDERED, that the Cash Management Banks are hereby authorized to continue to service and administer all such accounts as accounts of the Debtor as a debtor-in-possession without interruption and in the usual and ordinary course, and to receive, process, honor, and pay any and all checks and drafts drawn on, or electronic transfer requests made on, said account after the Petition Date by the holders or makers thereof, as the case may be; provided, however. that any check drawn or issued by the Debtor before the Petition Date may be honored by any |
bank only if specifically authorized by order of this Court and only to the extent of fands available in such Bank Account; and it is further ORDERED, that, except for those checks that may be honored and paid to comply with any order{s) of this Court authorizing payment of certain pre-petition claims, no checks or drafts issued on the Bank Accounts before the Petition Date but presented for payment after the Petition Date shall be honored or paid; and it is further ORDERED, that subject to the provisions of this Order, the operation of the Cash Management System in accordance with the Debtors normal and customary practice is adequate and sufficient; and it is further ORDERED, that, notwithstanding any other provision of this Order, no Cash Management Bank that honors a pre-petition check or other item drawn on any account that is the subject of this Order (a) at the direction of the Debtor, (b) in good-faith belief that the Court has authorized such pre-petition check or item to be honored or (c) as the result of an innocent mistake made despite implementation of reasonable item-handling procedures, shall be deemed to be liable to the Debtor or otherwise in violation of this Order; and it is further ORDERED, that nothing contained herein shall prevent the Debtor from opening any new bank accounts or closing any Bank Accounts as it may deem necessary and appropriate; provided, that the Debtor shall promptly notify the United States Trustee and any official committee prior to making any change to the Cash Management System, including the opening and closing of Bank Accounts; and it is further ORDERED, that the Debtor is authorized to continue to use their existing checks without alteration and without the designation Debtor-in-Possession imprinted upon them, provided, however, that following the depletion of the Debtors business form stock, the Debtor |
will obtain new check stock reflecting its status as a debtor-in-possession; provided farther, that with respect to Business Forms which the Debtor or its agents print themselves, the Debtor and its agents shall begin printing the Debtor in Possession legend on such items within ten (10) days of the date of entry of this Order; and it is farther ORDERED, that for Cash Management Banks at which the Debtor holds Bank Accounts that are party to a Uniform Depository agreement with the Office of the United States Trustee for the District of Delaware, within fifteen (15) days of the date of entry of this Order the Debtor shall (a) contact each Bank, (b) provide the Bank with the Debtors employer identification number(s) and (c) identify each of their Bank Accounts held at such Cash Management Banks as being held by a debtor in possession in a bankruptcy case; and it is further ORDERED, that for Cash Management Banks at which the Debtor holds Bank Accounts that are not party to a Uniform Depository agreement with the Office of the United States Trustee for the District of Delaware, the Debtor shall use its good-faith efforts to cause the bank to execute a Uniform Depository agreement in a form prescribed by the Office of the United States Trustee within forty-five (45) days of the date of this Order. The U.S. Trustees rights to seek further relief from this Court on notice in the event that the aforementioned Cash Management Bajiks are unwilling to execute a Uniform Depository Agreement in a form prescribed by the U.S. Trustee are fully reserved; and it is further ORDERED, that the preceding two paragraphs of this Order apply to any Bank Accounts opened by the Debtors subsequent to entry of this Order; provided, however, that the deadlines referenced in the paragraphs shall run from the respective dates on which the accounts are opened; provided further, that the Debtor shall provide contemporaneous notice of the |
closing and/or opening of any of the Bank Accounts to both the Office of the United States Trustee and any official cotnmittee(s) appointed in these cases; and it is further ORDERED, that the Debtor is authorized to make disbursements from Ihe Bank Accounts other than by check, to the extent consistent with the Debtors existing cash management practices; and it is further ORDERED, that, effective as of the Petition Date, the Cash Management Banks shall be and hereby are authorized aaJWtwtecno receive, process, honor, and pay any and all pre-petition and post-petition checks drawn on and electronic transfers authorized for payment by the Court, provided that funds are available in the applicable Bank Account; and it is further ORDERED, that the Debtor shall maintain records in accordance with its normal and customary practices reflecting al! transfers of funds under the terms and conditions provided by the existing agreements with the institutions participating in the Debtors Cash Management System. In connection with the ongoing utilization of its Cash Management System, the Debtor shall continue to maintain records with respect to all transfers of cash so that all transactions may be ascertained, traced, and recorded properly on the applicable accounts; and it is further ORDERED, that, through the Interim Period, the Debtor is authorized to deposit the estates money in accordance with the deposit practices set forth in the Motion or a commercially comparable practice, notwithstanding that such practice may not strictly comply in a!f instances with the requirements of Bankruptcy Code § 345 or the U.S. Trustees Guidelines; provided, however, that such extension is without prejudice to the Debtors right to request a further extension or the waiver of the requirements of section 345 of the Bankruptcy Code and this Order shall constitute notice that the Debtor is authorized to continue investing funds in the |
manner set forth in the Motion during the aforementioned seventy-five (75) day period, notwithstanding the requirements of section 345 of the Bankruptcy Code; and it is further ORDERED, that, notwithstanding the relief granted herein and any actions taken hereunder, nothing contained herein shall constitute, nor is intended to constitute, an assumption of any executory contract under Bankruptcy Code § 365; and it is further ORDERED, that this Order is effective immediately upon entry; and it is further ORDERED, that the Court shall retain jurisdiction with respect to all matters arising from or related to the implementation of this Order, Dated: December^ 2009 Wilmington, Delaware /j ^ THE HONORABLE CHRISTOPHER S, SONTCHI UNITED STATES BANKRUPTCY JUDGE |
Retainers Paid (Form IR-2) |
In re: Vion Pharmaceuticals, Inc. | Case No. 09-14429(CSS) | |
Reporting Period: Initial Monthly Report |
SCHEDULE OF RETAINER PAID TO PROFESSIONALS
(This schedule is to include each Professional paid a retainer1)
Check | Amount | |||||||||||||||||
Payee | Date | Number | Name of Payor | Amount | Applied To Date | Balance | ||||||||||||
Fulbright & Jaworski
LLP
|
12/15/2009 | Wire transfer | Vion Pharmaceuticals, Inc. | $ | 40,000 | $ | 0 | $ | 40,000 | |||||||||
Richards, Layton & Finger PA
|
11/5/2009 | Wire transfer | Vion Pharmaceuticals, Inc. | $ | 50,000 | |||||||||||||
12/16/2009 | Wire transfer | Vion Pharmaceuticals, Inc. | $ | 41,600 | ||||||||||||||
($91,600 total) | $ | 43,388.92 | $ | 48,211.08 (evergreen retainer) | ||||||||||||||
Delaware Claims
Agency, LLC
|
12/8/2009 | Check #32809 | Vion Pharmaceuticals, Inc. | $ | 5,000 | $ | 0 | $ | 5,000 |
1 | Identify all Evergreen Retainers |